Drug intelligence / Profile preview

Frilabiol Joint

Development stage
Unknown
Lead developer
FRiLAB
Modality
Small Molecules
Administration
Oral
01

Overview

Frilabiol Joint is an oral nutraceutical product marketed by **FRiLAB**, a Swiss pharmaceutical distribution and marketing company. It is part of the Frilabiol range of dietary supplements, which are designed to support various physiological functions including immunity, digestion, and sleep. Frilabiol Joint is specifically formulated to promote joint health, maintain cartilage integrity, and support overall mobility. The product typically functions as a combination supplement containing key structural components of joint tissue, such as glucosamine and chondroitin sulfate. These ingredients serve as precursors for the synthesis of glycosaminoglycans and proteoglycans, which are essential for the elasticity and shock-absorbing properties of articular cartilage. It is marketed as an over-the-counter (OTC) food supplement rather than a prescription pharmaceutical drug.

Brand names
Frilabiol JointFrilabiol Articulation
Other names
Frilabiol Joint-FRiLAB-oral

Beyond the preview

Go deeper on Frilabiol Joint.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frilabiol Joint.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call